Long noncoding RNA ST8SIA6‐AS1 promotes cell proliferation and metastasis in triple‐negative breast cancer by targeting miR‐145‐5p/CDCA3 to inactivate the p53/p21 signaling pathway. Issue 10 (22nd June 2022)

• Record Type: Journal Article
• Authors: Qiao, Yan; Wang, Bin; Yan, Yu; Niu, Ligang
• Is Part Of: Environmental toxicology. Volume 37:Issue 10(2022)
• Page Start: 2398
• Page End: 2411
• Publication Date: 2022-06-22
• Subjects: CDCA3 -- ceRNA -- lncRNAs -- p53/p21 signaling -- ST8SIA6‐AS1 -- triple‐negative breast cancer; Water quality bioassay -- Periodicals; Water -- Pollution -- Toxicology -- Periodicals; Microbiological assay -- Periodicals; Toxicity testing -- Periodicals; Environmental toxicology -- Periodicals; Environmental Pollution -- Periodicals; Environmental Pollutants -- Periodicals; Environmental Monitoring -- Periodicals; Écotoxicologie -- Périodiques; Pollution -- Périodiques; 615.902
• DOI: 10.1002/tox.23605
• Languages: English
• ISSNs: 1520-4081

Abstract

Abstract: Background: Triple‐negative breast cancer (TNBC), the most aggressive subtype of breast cancer, always exhibits a poor prognosis due to high risk of early recurrence and distant metastasis. Long noncoding RNAs (lncRNAs) have been reported as crucial regulators in breast cancer. However, the functions and action mechanisms of lncRNA ST8SIA6‐AS1 in TNBC are largely unknown. Methods: Quantitative real‐time PCR and western blot assays were used to measure the expression levels of different genes and proteins. Cell proliferation ability was monitored by CCK‐8, colony forming and flow cytometry assays. Wound healing and transwell assays were performed to evaluate cell migration and invasion. The regulatory mechanisms of ST8SIA6‐AS1 in TNBC were confirmed by dual luciferase reporter and RIP assays. A mouse xenograft model was established to investigate the role of ST8SIA6‐AS1 in TNBC tumor growth. Results: ST8SIA6‐AS1 displayed a higher expression in TNBC cells. Silencing ST8SIA6‐AS1 impaired cell proliferation, cell cycle progression, migration, and invasion in vitro, and slowed tumor growth in vivo. Mechanistically, ST8SIA6‐AS1 could facilitate the expression of its target CDCA3 (cell division cycle associated protein 3) and inactivate the p53/p21 signaling by inhibiting miR‐145‐5p. Moreover, miR‐145‐5p exerted a tumor‐suppressive activity by targeting CDCA3. The tumor‐suppressive effects induced by ST8SIA6‐AS1 knockdown were abated by the down‐regulation of miR‐145‐5p or the up‐regulation of CDCA3. Conclusion: ST8SIA6‐AS1 exerts an oncogenic role in TNBC by interacting with miR‐145‐5p to up‐regulate CDCA3 expression and inactivate the p53/p21 signaling, highlighting ST8SIA6‐AS1 as a promising molecular target to combat TNBC.